The report was released on December 12, 2021. The BOŚ Brokerage House analysts started to issue a “buy” recommendation for PolTREG from with a target price of PLN 133.1.
Source:
2021-12-12
Brokerage House of Bank Ochrony Środowiska recommends “buy” for PolTREG
See other news
2023-06-15
PolTREG is expanding its cGMP capabilities, which are currently out-sourced, with the announcement of the completion of the first stage investment in and construction of its own state-of-the art cell and gene therapy manufacturing facility
2023-05-25
Prof. Piotr Trzonkowski, CEO of PolTREG has been awarded the Wprost Health Visioner 2023 Award
